Literature DB >> 8060916

Elevated serum levels of IgE-binding factor/soluble CD23 in bullous pemphigoid.

F Furukawa1, S Kumagai, Y Sakamoto, M Takigawa, S Imamura.   

Abstract

IgE-related abnormalities and impaired B cell function have been reported in patients with bullous pemphigoid (BP). CD23 is a low affinity Fc epsilon RII on haematopoietic cells and its soluble form (sCD23) is involved in B cell growth and differentiation. In order to determine the role of CD23 in the pathomechanisms of BP, the present study assayed the level of sCD23 in sera of BP patients using an ELISA method. Levels of sCD23 were elevated in BP patients compared with mean levels in the sera of normal control. Furthermore, the increase in sCD23 levels correlated with the degree of disease activity. A significant correlation was found between sCD23 and serum IgE levels in BP sera, but not in normal control sera. These results suggest that sCD23 is an important index for monitoring BP with respect to IgE-related abnormalities and impaired B cell function.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8060916     DOI: 10.1016/0923-1811(94)90089-2

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  5 in total

Review 1.  Targeted Therapies for Autoimmune Bullous Diseases: Current Status.

Authors:  Kyle T Amber; Roberto Maglie; Farzan Solimani; Rüdiger Eming; Michael Hertl
Journal:  Drugs       Date:  2018-10       Impact factor: 9.546

2.  IgE antibodies in sera from patients with bullous pemphigoid are autoantibodies preferentially directed against the 230-kDa epidermal antigen (BP230)

Authors:  R F Ghohestani; E Cozzani; E Delaporte; J F Nicolas; A Parodi; A Claudy
Journal:  J Clin Immunol       Date:  1998-05       Impact factor: 8.317

Review 3.  The Intersection of IgE Autoantibodies and Eosinophilia in the Pathogenesis of Bullous Pemphigoid.

Authors:  Kelly N Messingham; Tyler P Crowe; Janet A Fairley
Journal:  Front Immunol       Date:  2019-10-04       Impact factor: 7.561

Review 4.  IgE autoantibodies and their association with the disease activity and phenotype in bullous pemphigoid: a systematic review.

Authors:  Ariadne Hadjikyriacou Saniklidou; Patrick J Tighe; Lucy C Fairclough; Ian Todd
Journal:  Arch Dermatol Res       Date:  2017-10-25       Impact factor: 3.017

Review 5.  Emerging Biomarkers and Therapeutic Strategies for Refractory Bullous Pemphigoid.

Authors:  Tong Zhou; Bin Peng; Songmei Geng
Journal:  Front Immunol       Date:  2021-08-24       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.